N-(2-methylcyclohexyl)-2,3,4,5,6-pentafluorobenzamide

N-(2-methylcyclohexyl)-2,3,4,5,6-pentafluorobenzamide (CAS Number: 1003050-32-5) is a synthetic organic compound classified as a flavoring agent or flavoring adjuvant. The molecule consists of a pentafluorobenzamide core—a benzene ring with five fluorine atoms and an amide functional group—attached to a 2-methylcyclohexyl side chain. This structural composition places it within the category of fluorinated flavor compounds, a specialized subset of synthetic flavorings developed for specific sensory applications.

As a flavoring agent, this compound is intended for use in food and beverage products where it contributes to overall flavor profiles. The specific flavor characteristics it imparts have been designed at the molecular level through its unique chemical structure. While detailed proprietary applications may vary by manufacturer, synthetic flavor compounds of this type are typically employed in processed foods, beverages, confectionery, or dairy products in very small quantities. Like most flavoring agents, it would be used at levels well below those that would have any nutritional significance, with its primary function being sensory enhancement.

The safety profile of this additive is characterized by limited publicly available toxicological data. The FDA has not granted this substance GRAS (Generally Recognized As Safe) status, which indicates that it has not undergone the standard GRAS notification process or has not been approved through that pathway. However, this classification does not inherently indicate concern—rather, it reflects that formal FDA safety approval through standard mechanisms has not been completed or submitted.

According to FDA records, there have been zero adverse events reported and zero product recalls associated with this additive. The absence of adverse event reports suggests that if the compound has been in use, it has not generated consumer safety complaints or documented health concerns that reached FDA attention. The lack of recalls similarly indicates no identified safety issues requiring market withdrawal.

The fluorinated nature of this compound warrants consideration, as fluorine-containing compounds have varied safety profiles depending on their specific chemical structure and metabolism. However, the presence of fluorine does not automatically raise safety concerns; many approved food additives and medications contain fluorine atoms without documented adverse effects at intended use levels.

This additive does not have FDA GRAS status. In the United States, food additives either obtain GRAS status through established use or scientific procedures, or they require approval as food additives through a formal petition process. The regulatory pathway for this specific compound remains unclear from public FDA records, and it may be in development, under review, or pending submission.

International regulatory status should be independently verified, as different countries maintain distinct approval processes through bodies such as the European Food Safety Authority (EFSA), Health Canada, or other national food safety agencies. Manufacturers intending to use this additive must comply with applicable regulations in their target markets.

Publicly available peer-reviewed toxicological or safety studies specific to this compound appear limited in the open literature. The lack of published safety data is not uncommon for proprietary synthetic flavor compounds, particularly those not yet widely commercialized. Any safety assessments would likely exist within confidential FDA dossiers or manufacturer documentation submitted as part of regulatory review processes.

For additives lacking GRAS status and with limited public safety data, additional toxicological testing—including acute toxicity, genotoxicity, and chronic exposure studies—may be required before regulatory approval in various jurisdictions.